Skip to content

Ethos Technologies, Inc. LIFE Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Merck & Co. logo
Merck & Co.MRK
$157M+726%
United Therapeutics logo
United TherapeuticsUTHR
$68.3M+311%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$60.88M
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
$19.91M
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.21M+219%
Zymeworks logo
ZymeworksZYME
$8.72M+1,029%

Other financials

Income statement

See full
Revenue-
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$1.14B+20.6%
Enterprise value$1.14B
P/S6,001×

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Reported directly by Ethos Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Ethos Technologies, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ethos Technologies, Inc. 's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ethos Technologies, Inc. 's stock issuance proceeds?
Ethos Technologies, Inc. (LIFE) reported stock issuance proceeds of $0 in Q1 2026.
How has Ethos Technologies, Inc. 's stock issuance proceeds changed year-over-year?
Ethos Technologies, Inc. 's stock issuance proceeds decreased by 100.0% year-over-year, from $2K to $0.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.